Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rheumensa is a topical Ayurvedic cream and ointment developed and manufactured by Dollar Company. It is formulated with a blend of traditional Indian herbs and natural ingredients, including Bala (*Sida cordifolia*), Ajamoda (*Carum roxburghianum*), Nilgirika Tel (Eucalyptus oil), Pudina ka Phul (Mentha arvensis), Karpora (Camphor), Devadaru (*Cedrus deodara*), and Nirgundi (*Vitex negundo*). Rheumensa is indicated for the relief of musculoskeletal discomfort, including joint and muscle pain, back pain, neck pain, sprains, inflammation, and joint stiffness associated with arthritis and other skeletal disorders. The formulation penetrates deeply into tissues to provide a cooling sensation, reduce swelling, and improve limb mobility.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Rheumensa.